Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Bernd Hagen"'
Autor:
Bernd Hagen
Publikováno v:
Journal of European CME, Vol 11, Iss 1 (2022)
Disease Management Programmes (DMPs) have been introduced by German Federal Government in 2002 to improve long-term care for patients with specific chronic diseases. Digitisation has been a requirement to reliably document patient data in DMPs. This
Externí odkaz:
https://doaj.org/article/a319d67652434ed6a9662f7544f69b30
Autor:
Uwe Konerding, Marcus Redaèlli, Karolin Ackermann, Sibel Altin, Sebastian Appelbaum, Bianca Biallas, August-Wilhelm Bödecker, Suzan Botzenhardt, Chloé Chermette, Martin Cichocki, Iris Dapper, Katja Dehnen, Christian Funke, Angeli Gawlik, Lisa Giesen, Johannes Goetz, Christian Graf, Bernd Hagen, Martina Heßbrügge, Phillip Hendrick Höhne, Jens Kleinert, Helene Könnecke, Lucas Küppers, Nicole Kuth, Lion Lehmann, Claas Lendt, Khalid Majjouti, Yeliz Nacak, Aliza Neuhausen, Larisa Pilic, Lara Schneider, Maximilian Scholl, Dusan Simic, Andreas Sönnichsen, Anika Thielmann, Ines Van der Arend, Frank Vitinius, Birgitta Weltermann, Dorothea Wild, Stefan Wilm, Stephanie Stock
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-17 (2021)
Abstract Background Type 2 diabetes mellitus (T2DM) and coronary heart disease (CHD) are two chronic diseases that cause a tremendous burden. To reduce this burden, several programmes for optimising the care for these diseases have been developed. In
Externí odkaz:
https://doaj.org/article/ceb70baa37af48b49609ee0864d88264
Autor:
Christian Schmidt, Christin Heidemann, Alexander Rommel, Ralph Brinks, Heiner Claessen, Jochen Dreß, Bernd Hagen, Annika Hoyer, Gunter Laux, Johannes Pollmanns, Maximilian Präger, Julian Böhm, Saskia Drösler, Andrea Icks, Stephanie Kümmel, Christoph Kurz, Tatjana Kvitkina, Michael Laxy, Werner Maier, Maria Narres, Joachim Szecsenyi, Thaddäus Tönnies, Maria Weyermann, Rebecca Paprott, Lukas Reitzle, Jens Baumert, Eleni Patelakis, Thomas Ziese
Publikováno v:
Journal of Health Monitoring, Vol 4, Iss 2, Pp 50-63 (2019)
In addition to the Robert Koch Institute’s health surveys, analyses of secondary data are essential to successfully developing a regular and comprehensive description of the progression of diabetes as part of the Robert Koch Institute’s diabetes
Externí odkaz:
https://doaj.org/article/476aa7a79e5f426692460d0e21bf3274
Autor:
Bernd Hagen, Reinhard Griebenow
Publikováno v:
Journal of European CME, Vol 9, Iss 1 (2020)
Physicians always aim to improve their patients’ health. CME should be designed not only to provide knowledge transfer, but also to influence clinical decision-making and to close performance gaps. In aretrospective study we analysed prescription r
Externí odkaz:
https://doaj.org/article/4899b4ee084e4c96a84ab1fd7eb4de55
Autor:
Lars Gabrys, Christin Heidemann, Christian Schmidt, Jens Baumert, Andrea Teti, Yong Du, Rebecca Paprott, Thomas Ziese, Winfried Banzer, Michael Böhme, Brigitte Borrmann, Reinhard Busse, Michael Freitag, Bernd Hagen, Reinhard Holl, Andrea Icks, Matthias Kaltheuner, Klaus Koch, Stefanie Kümmel, Joseph Kuhn, Oliver Kuß, Gunter Laux, Ingrid Schubert, Joachim Szecsenyi, Til Uebel, Daniela Zahn, Christa Scheidt-Nave
Publikováno v:
Journal of Health Monitoring, Vol 3, Iss S3, Pp 3-21 (2018)
Mainly because of the large number of people affected and associated significant health policy implications, the Robert Koch Institute (RKI) is developing a public health surveillance system using diabetes as an example. In a first step to ensure lon
Externí odkaz:
https://doaj.org/article/b2666b6c19254e9396c72607fa160c23
Publikováno v:
Journal of European CME, Vol 3, Iss 0, Pp 1-10 (2014)
Objective. This study investigates whether introducing targeted CME into a regular feedback system being part of a disease management programme (DMP) will improve prescription behaviour, and if yes, how long it will take to demonstrate this effect an
Externí odkaz:
https://doaj.org/article/66ffaae504f145af9351dc161ddb9b1a
Autor:
Bernd Hagen
Publikováno v:
Public Health Forum. 29:357-361
Zusammenfassung In dem DMP Typ-2-Diabetes wurden Mitte 2020 bundesweit ca. 4,4 Millionen Patienten betreut, davon in NRW bis Ende 2019 mehr als 1 Million. Dort erreicht das DMP damit ca. 83–91% der erwarteten GKV-Patienten mit Typ-2-Diabetes. Von d
Autor:
Claas Lendt, Marcus Redaèlli, Angeli Gawlik, Martin Cichocki, Iris Dapper, Stephanie Stock, Lara Schneider, Yeliz Nacak, Uwe Konerding, Helene Könnecke, Christian Funke, Phillip Hendrick Höhne, Katja Dehnen, Jens Kleinert, Dusan Simic, Martina Heßbrügge, Suzan Botzenhardt, August-Wilhelm Bödecker, Karolin Ackermann, Dorothea Wild, Chloé Chermette, Sibel Altin, Maximilian Scholl, Bianca Biallas, Christian Graf, Khalid Majjouti, Andreas Sönnichsen, Lucas Küppers, Sebastian Appelbaum, Larisa Pilic, Johannes Goetz, Nicole Kuth, Aliza Neuhausen, Lisa Giesen, Frank Vitinius, Ines Van der Arend, Bernd Hagen, Birgitta Weltermann, Anika Thielmann, Stefan Wilm, Lion Lehmann
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-17 (2021)
Trials
Trials
Background Type 2 diabetes mellitus (T2DM) and coronary heart disease (CHD) are two chronic diseases that cause a tremendous burden. To reduce this burden, several programmes for optimising the care for these diseases have been developed. In Germany,
Autor:
Bernd Hagen, Sabine Groos
Publikováno v:
Hand in Hand zum Ziel – einfach.besser.messbar www.diabeteskongress.de.
Autor:
Sabine Groos, Bernd Hagen
Publikováno v:
Hand in Hand zum Ziel – einfach.besser.messbar www.diabeteskongress.de.